Skip to main content
Clinical Trials/IRCT2014122020374N1
IRCT2014122020374N1
Completed
Phase 3

A survey of effect of vitamin E supplement on advanced glycation end products, oxidative stress and inflammatory markers in diabetic nephropathy patients

Kashan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
diabetic nephropathy.
Sponsor
Kashan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient with diabetic nephropathy
  • Aged 40 to 85 years
  • Proteinuria level \> 0\.3 g/24 h with or without circulating levels of serum creatinine.

Exclusion Criteria

  • The consumption of vitamin E supplements within 3 months
  • Patients with uncontrolled diabetes,
  • Pregnant women
  • Those with liver or inflammatory diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials